The structure-inhibitory activity relationships study in a series of cyclooxygenase-2 inhibitors: A combined electronic-topological and neural networks approach

被引:11
作者
Dimoglo, A
Kovalishyn, V
Shvets, N
Ahsen, V
机构
[1] Gebze Inst Technol, TR-41400 Kocaeli, Turkey
[2] Inst Chem, Dept Quantum Chem, Kishinev 2028, Moldova
[3] Inst Bioorgan & Petr Chem, UA-253660 Kiev, Ukraine
[4] Moldavian Acad Sci, Inst Math, Kishinev 2028, Moldova
关键词
COX-2; inhibitors; structure-activity relationships; electronic-topological method; neural networks;
D O I
10.2174/138955705774329537
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-activity relationships study was performed for a few series of cyclooxygenase-2 (COX-2) inhibitors by using the Electronic-Topological Method combined with Neural Networks (ETM-NN). Specific molecular fragments were found for active compounds ('activity features') from both series by the ETM application. After this, a system of prognosis was developed as the result of training Kohonen's self organizing maps (SOM) by the fragments. From the detailed analysis of all compounds under study, requirements necessary for a compound to be COX-2 inhibitor were formulated. The analysis showed that any requirements violation for a molecule resulted in a considerable decrease or even complete loss of its activity. The found activity features identified correctly different marketed drugs and new compounds that had passed pre-clinical and clinical trials; this fact confirms the workability of the system developed for the COX-2 inhibitory activity prediction.
引用
收藏
页码:879 / 892
页数:14
相关论文
共 66 条
  • [31] Pyridazinones as selective cyclooxygenase-2 inhibitors
    Li, CS
    Brideau, C
    Chan, CC
    Savoie, C
    Claveau, D
    Charleson, S
    Gordon, R
    Greig, G
    Gauthier, JY
    Lau, CK
    Riendeau, D
    Thérien, M
    Wong, E
    Prasit, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 597 - 600
  • [32] CYCLOOXYGENASE-2 INHIBITORS - SYNTHESIS AND PHARMACOLOGICAL ACTIVITIES OF 5-METHANESULFONAMIDO-1-INDANONE DERIVATIVES
    LI, CS
    BLACK, WC
    CHAN, CC
    FORDHUTCHINSON, AW
    GAUTHIER, JY
    GORDON, R
    GUAY, D
    KARGMAN, S
    LAU, CK
    MANCINI, J
    OUIMET, N
    ROY, P
    VICKERS, P
    WONG, E
    YOUNG, RN
    ZAMBONI, R
    PRASIT, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) : 4897 - 4905
  • [33] Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents
    Li, JJ
    Norton, MB
    Reinhard, EJ
    Anderson, GD
    Gregory, SA
    Isakson, PC
    Koboldt, CM
    Masferrer, JL
    Perkins, WE
    Seibert, K
    Zhang, Y
    Zweifel, BS
    Reitz, DB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) : 1846 - 1856
  • [34] Differential binding mode of diverse cyclooxygenase inhibitors
    Llorens, O
    Perez, JJ
    Palomer, A
    Mauleon, D
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (05) : 359 - 371
  • [35] Lombardino G., 1985, NONSTEROIDAL ANTIINF
  • [36] QSAR analysis of cyclooxygenase inhibitor using particle swarm optimization and multiple linear regression
    Lü, JX
    Shen, Q
    Jiang, JH
    Shen, GL
    Yu, RQ
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (04) : 679 - 687
  • [37] Neural networks in drug discovery: have they lived up to their promise?
    Manallack, DT
    Livingstone, DJ
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (03) : 195 - 208
  • [38] COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs
    Moore, BC
    Simmons, DL
    [J]. CURRENT MEDICINAL CHEMISTRY, 2000, 7 (11) : 1131 - 1144
  • [39] Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors
    Paramashivappa, R
    Kumar, PP
    Rao, PVS
    Rao, AS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 657 - 660
  • [40] Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)
    Penning, TD
    Talley, JJ
    Bertenshaw, SR
    Carter, JS
    Collins, PW
    Docter, S
    Graneto, MJ
    Lee, LF
    Malecha, JW
    Miyashiro, JM
    Rogers, RS
    Rogier, DJ
    Yu, SS
    Anderson, GD
    Burton, EG
    Cogburn, JN
    Gregory, SA
    Koboldt, CM
    Perkins, WE
    Seibert, K
    Veenhuizen, AW
    Zhang, YY
    Isakson, PC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) : 1347 - 1365